Last reviewed · How we verify
Fat emulsion with MCT and LCT
Fat emulsion with MCT and LCT is a Parenteral nutrition emulsion Small molecule drug developed by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. It is currently FDA-approved for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Nutritional support in critical illness, post-operative recovery, and malabsorption disorders.
A nutritional emulsion combining medium-chain triglycerides (MCT) and long-chain triglycerides (LCT) that provides readily absorbable lipid-based calories and essential fatty acids for parenteral nutrition.
A nutritional emulsion combining medium-chain triglycerides (MCT) and long-chain triglycerides (LCT) that provides readily absorbable lipid-based calories and essential fatty acids for parenteral nutrition. Used for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Nutritional support in critical illness, post-operative recovery, and malabsorption disorders.
At a glance
| Generic name | Fat emulsion with MCT and LCT |
|---|---|
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Drug class | Parenteral nutrition emulsion |
| Modality | Small molecule |
| Therapeutic area | Nutrition support / Critical care |
| Phase | FDA-approved |
Mechanism of action
MCT/LCT fat emulsions are used in intravenous nutrition to deliver energy substrates and essential fatty acids to patients unable to consume food orally or enterally. MCTs are more rapidly hydrolyzed and absorbed than LCTs alone, while LCTs provide essential polyunsaturated fatty acids. The combination optimizes both rapid energy availability and nutritional completeness.
Approved indications
- Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition
- Nutritional support in critical illness, post-operative recovery, and malabsorption disorders
Common side effects
- Hypertriglyceridemia
- Phlebitis at infusion site
- Lipemia
- Allergic reactions
Key clinical trials
- Lipid Emulsions and Liver Function - Results After 5 Years. (PHASE4)
- Parenteral Lipid Emulsions and the Liver Function (PHASE4)
- Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis (PHASE4)
- Pure Fish Oil Parenteral Lipid Emulsion in Patients With Gastrointestinal Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fat emulsion with MCT and LCT CI brief — competitive landscape report
- Fat emulsion with MCT and LCT updates RSS · CI watch RSS
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau portfolio CI
Frequently asked questions about Fat emulsion with MCT and LCT
What is Fat emulsion with MCT and LCT?
How does Fat emulsion with MCT and LCT work?
What is Fat emulsion with MCT and LCT used for?
Who makes Fat emulsion with MCT and LCT?
What drug class is Fat emulsion with MCT and LCT in?
What development phase is Fat emulsion with MCT and LCT in?
What are the side effects of Fat emulsion with MCT and LCT?
Related
- Drug class: All Parenteral nutrition emulsion drugs
- Manufacturer: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau — full pipeline
- Therapeutic area: All drugs in Nutrition support / Critical care
- Indication: Drugs for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition
- Indication: Drugs for Nutritional support in critical illness, post-operative recovery, and malabsorption disorders
- Compare: Fat emulsion with MCT and LCT vs similar drugs
- Pricing: Fat emulsion with MCT and LCT cost, discount & access